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Sir,
The paper by Baeyens et al (2002) is interesting and we would
like to contribute to the discussion. The authors suggest that the
lack of correlation observed between G2 and G0 chromosomal
radiosensitivity, also observed by Scott et al (1994), could be
attributable to different DNA damage processing mechanisms
operating in the G0 and G2 phase of the cell cycle.
It is also possible that different radiation pathways are involved.
The G2 assay was performed following a dose of 0.4Gy. We and
others have demonstrated that this is the dose where maximal
indirect nontargeted radiation cell killing (the bystander effect)
occurs (Seymour and Mothersill, 2000). In our experience this
effect plateaus at this dose, and a dose-dependent cell killing then
follows. G0 is a specific stage of the cell cycle, which in the past has
been demonstrated to allow PLD repair, that is potentially lethal
damage that would in fact be lethal were the cell not in G0 (Hall,
2000). The observed result with 3.5Gy HDR (45% radiosensitive)
compared with the G2 results for 0.4Gy (43% radiosensitive) could
be interpreted as suggesting that radiosensitivity is independent of
direct radiation damage, and is rather a function of indirect effects.
The lack of correlation between the end points (G2-HDR MN
r¼0.04 and G2-LDR MN r¼0.05) could then be attributable to
differences in bystander expression during different stages of
the cell cycle. The effect of the low dose rate in increasing the
radiosensitivity is difficult to explain in terms of conventional
radiobiology, but an inverse dose rate effect is well documented
in the literature (Geard et al, 1994). The role of genetic
predisposition to cancer in determining G2 radiosensitivity is also
interesting. Our group has shown genetic variation of bystander-
induced cell death (Mothersill et al, 2001), but our interpretation
has been to link cancer proneness with lack of cell death following
exposure of unirradiated cells to the medium harvested from
irradiated cells. Clearly this is an interesting area awaiting
clarification.
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